טוען...
Troglitazone suppresses glutamine metabolism through a PPAR-independent mechanism
Enhanced glutamine metabolism is required for tumor cell growth and survival, which suggests that agents targeting glutaminolysis may have utility within anti-cancer therapies. Troglitazone, a PPARγ agonist, exhibits significant anti-tumor activity and can alter glutamine metabolism in multiple cell...
שמור ב:
| הוצא לאור ב: | Biol Chem |
|---|---|
| Main Authors: | , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2015
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4824301/ https://ncbi.nlm.nih.gov/pubmed/25872876 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1515/hsz-2014-0307 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|